9
Apr

Chemence Medical Receives FDA Approval for Exofin Fusion® Redesign

Medical technologies manufacturer improves patient care with enhanced skin closure system

Alpharetta, GA — Chemence Medical, a world leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion® skin closure system.

Read more